FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220792502> ?p ?o ?g. }

• W4220792502 endingPage "1047" @default.
• W4220792502 startingPage "1043" @default.
• W4220792502 abstract "Abstract Purpose One of the most critical issues in the management of Hodgkin lymphoma (HL) patients who resulted as primary relapsed or refractory is to obtain a minimal disease status before autologous stem cell transplantation (ASCT). Finding a salvage regimen able to induce this status without severe toxicity would represent a major achievement in this setting. Methods A single‐center retrospective study was conducted to assess effectiveness and safety of BEGEV (bendamustine, gemcitabine, and vinorelbine) regimen as first salvage setting prior to ASCT in HL patients. Results Forty-three patients were treated in our institution between October 2017 and November 2020. Median age at BEGEV therapy was 35.0 years (range 17.2– 70.0), and the median time from frontline therapy to the first cycle of BEGEV was 79.5 days (range 4–2267). At the end of treatment, 31 patients achieved a complete response (CR), with an overall response rate of 76.7%. Forty-one patients harvested CD34+ cells and 35/43 (81.4%) patients underwent ASCT. With a median follow‐up of 22 months, 4 CR patients had disease relapse, yielding an estimated disease-free survival of 73.9% at 34 months. The estimated 2‐year progression-free survival was 66.7%. Response to first-line chemotherapy did not significantly influence prognosis. Conclusions BEGEV regimen was well tolerated, and reversible haematological toxic effects were the most common adverse events. Real-life data on BEGEV regimen as first salvage setting showed a relevant rate of objective responses and a limited myelotoxicity with no impairment of a subsequent mobilization of peripheral blood stem cells." @default.
• W4220792502 created "2022-04-03" @default.
• W4220792502 creator A5012561249 @default.
• W4220792502 creator A5036092655 @default.
• W4220792502 creator A5039739851 @default.
• W4220792502 creator A5044832096 @default.
• W4220792502 creator A5046793649 @default.
• W4220792502 creator A5058320427 @default.
• W4220792502 creator A5065207434 @default.
• W4220792502 creator A5070351821 @default.
• W4220792502 creator A5079619055 @default.
• W4220792502 creator A5084168169 @default.
• W4220792502 creator A5090561717 @default.
• W4220792502 date "2022-03-03" @default.
• W4220792502 modified "2023-10-14" @default.
• W4220792502 title "BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma: a real-life experience" @default.
• W4220792502 cites W1997194652 @default.
• W4220792502 cites W2034218339 @default.
• W4220792502 cites W2093787801 @default.
• W4220792502 cites W2100017287 @default.
• W4220792502 cites W2112065237 @default.
• W4220792502 cites W2122654415 @default.
• W4220792502 cites W2129453071 @default.
• W4220792502 cites W2140104756 @default.
• W4220792502 cites W2141082026 @default.
• W4220792502 cites W2148775441 @default.
• W4220792502 cites W2157717016 @default.
• W4220792502 cites W2159746531 @default.
• W4220792502 cites W2160483964 @default.
• W4220792502 cites W2463754429 @default.
• W4220792502 cites W2899940507 @default.
• W4220792502 cites W2998942092 @default.
• W4220792502 doi "https://doi.org/10.1007/s00432-022-03955-w" @default.
• W4220792502 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35239000" @default.
• W4220792502 hasPublicationYear "2022" @default.
• W4220792502 type Work @default.
• W4220792502 citedByCount "1" @default.
• W4220792502 countsByYear W42207925022023 @default.
• W4220792502 crossrefType "journal-article" @default.
• W4220792502 hasAuthorship W4220792502A5012561249 @default.
• W4220792502 hasAuthorship W4220792502A5036092655 @default.
• W4220792502 hasAuthorship W4220792502A5039739851 @default.
• W4220792502 hasAuthorship W4220792502A5044832096 @default.
• W4220792502 hasAuthorship W4220792502A5046793649 @default.
• W4220792502 hasAuthorship W4220792502A5058320427 @default.
• W4220792502 hasAuthorship W4220792502A5065207434 @default.
• W4220792502 hasAuthorship W4220792502A5070351821 @default.
• W4220792502 hasAuthorship W4220792502A5079619055 @default.
• W4220792502 hasAuthorship W4220792502A5084168169 @default.
• W4220792502 hasAuthorship W4220792502A5090561717 @default.
• W4220792502 hasBestOaLocation W42207925021 @default.
• W4220792502 hasConcept C121332964 @default.
• W4220792502 hasConcept C126322002 @default.
• W4220792502 hasConcept C141071460 @default.
• W4220792502 hasConcept C142424586 @default.
• W4220792502 hasConcept C143998085 @default.
• W4220792502 hasConcept C197934379 @default.
• W4220792502 hasConcept C2776694085 @default.
• W4220792502 hasConcept C2778239845 @default.
• W4220792502 hasConcept C2779050716 @default.
• W4220792502 hasConcept C2779338263 @default.
• W4220792502 hasConcept C2780258809 @default.
• W4220792502 hasConcept C2780350996 @default.
• W4220792502 hasConcept C2780653079 @default.
• W4220792502 hasConcept C2780775027 @default.
• W4220792502 hasConcept C2781413609 @default.
• W4220792502 hasConcept C2781442060 @default.
• W4220792502 hasConcept C2911091166 @default.
• W4220792502 hasConcept C71924100 @default.
• W4220792502 hasConcept C87355193 @default.
• W4220792502 hasConceptScore W4220792502C121332964 @default.
• W4220792502 hasConceptScore W4220792502C126322002 @default.
• W4220792502 hasConceptScore W4220792502C141071460 @default.
• W4220792502 hasConceptScore W4220792502C142424586 @default.
• W4220792502 hasConceptScore W4220792502C143998085 @default.
• W4220792502 hasConceptScore W4220792502C197934379 @default.
• W4220792502 hasConceptScore W4220792502C2776694085 @default.
• W4220792502 hasConceptScore W4220792502C2778239845 @default.
• W4220792502 hasConceptScore W4220792502C2779050716 @default.
• W4220792502 hasConceptScore W4220792502C2779338263 @default.
• W4220792502 hasConceptScore W4220792502C2780258809 @default.
• W4220792502 hasConceptScore W4220792502C2780350996 @default.
• W4220792502 hasConceptScore W4220792502C2780653079 @default.
• W4220792502 hasConceptScore W4220792502C2780775027 @default.
• W4220792502 hasConceptScore W4220792502C2781413609 @default.
• W4220792502 hasConceptScore W4220792502C2781442060 @default.
• W4220792502 hasConceptScore W4220792502C2911091166 @default.
• W4220792502 hasConceptScore W4220792502C71924100 @default.
• W4220792502 hasConceptScore W4220792502C87355193 @default.
• W4220792502 hasIssue "3" @default.
• W4220792502 hasLocation W42207925021 @default.
• W4220792502 hasLocation W42207925022 @default.
• W4220792502 hasLocation W42207925023 @default.
• W4220792502 hasLocation W42207925024 @default.
• W4220792502 hasOpenAccess W4220792502 @default.
• W4220792502 hasPrimaryLocation W42207925021 @default.
• W4220792502 hasRelatedWork W1990438752 @default.
• W4220792502 hasRelatedWork W2078127843 @default.

• next